BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 28089971)

  • 1. Incidence of Malignancy Prior to Antineutrophil Cytoplasmic Antibody-associated Vasculitis Compared to the General Population.
    van Daalen EE; Rahmattulla C; Wolterbeek R; Bruijn JA; Bajema IM
    J Rheumatol; 2017 Mar; 44(3):314-318. PubMed ID: 28089971
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Malignancy is increased in patients with antineutrophil cytoplasmic antibody-associated vasculitis in China.
    Han XY; Li ZY; Zhao MH; Little MA; Chen M
    Arthritis Res Ther; 2024 May; 26(1):113. PubMed ID: 38822382
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Incidence of malignancy in patients treated for antineutrophil cytoplasm antibody-associated vasculitis: follow-up data from European Vasculitis Study Group clinical trials.
    Heijl C; Harper L; Flossmann O; Stücker I; Scott DG; Watts RA; Höglund P; Westman K; Mahr A;
    Ann Rheum Dis; 2011 Aug; 70(8):1415-21. PubMed ID: 21616914
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The epidemiology of antineutrophil cytoplasmic antibody-associated vasculitis in northwestern Turkey.
    Pamuk ÖN; Dönmez S; Calayır GB; Pamuk GE
    Clin Rheumatol; 2016 Aug; 35(8):2063-2071. PubMed ID: 26992904
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Malignancies in Patients with Antineutrophil Cytoplasmic Antibody-associated Vasculitis: A Population-based Cohort Study.
    Heijl C; Westman K; Höglund P; Mohammad AJ
    J Rheumatol; 2020 Aug; 47(8):1229-1237. PubMed ID: 31474595
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Incidence of Malignancies in Patients With Antineutrophil Cytoplasmic Antibody-Associated Vasculitis Diagnosed Between 1991 and 2013.
    Rahmattulla C; Berden AE; Wakker SC; Reinders ME; Hagen EC; Wolterbeek R; Bruijn JA; Bajema IM
    Arthritis Rheumatol; 2015 Dec; 67(12):3270-8. PubMed ID: 26246307
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cancer development in Korean patients with ANCA-associated vasculitis: a single centre study.
    Yoo J; Ahn SS; Jung SM; Song JJ; Park YB; Lee SW
    Clin Exp Rheumatol; 2018; 36 Suppl 111(2):73-77. PubMed ID: 29465366
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antineutrophil cytoplasmic antibody-associated vasculitis and malignancy.
    Wester Trejo MAC; Bajema IM; van Daalen EE
    Curr Opin Rheumatol; 2018 Jan; 30(1):44-49. PubMed ID: 28957961
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of rituximab on malignancy risk in patients with ANCA-associated vasculitis.
    van Daalen EE; Rizzo R; Kronbichler A; Wolterbeek R; Bruijn JA; Jayne DR; Bajema IM; Rahmattulla C
    Ann Rheum Dis; 2017 Jun; 76(6):1064-1069. PubMed ID: 27899372
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The cancer risk according to three subtypes of ANCA-associated vasculitis: A propensity score-matched analysis of a nationwide study.
    Choi ST; Ahn SV; Lee PH; Moon CM
    Semin Arthritis Rheum; 2021 Aug; 51(4):692-699. PubMed ID: 34139522
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antineutrophil cytoplasmic antibody-associated vasculitis in Taiwan: A hospital-based study with reference to the population-based National Health Insurance database.
    Wu CS; Hsieh CJ; Peng YS; Chang TH; Wu ZY
    J Microbiol Immunol Infect; 2015 Oct; 48(5):477-82. PubMed ID: 24560699
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characteristics and Outcomes of Granulomatosis With Polyangiitis (Wegener) and Microscopic Polyangiitis Requiring Renal Replacement Therapy: Results From the European Renal Association-European Dialysis and Transplant Association Registry.
    Hruskova Z; Stel VS; Jayne D; Aasarød K; De Meester J; Ekstrand A; Eller K; Heaf JG; Hoitsma A; Martos Jimenéz C; Ravani P; Wanner C; Tesar V; Jager KJ
    Am J Kidney Dis; 2015 Oct; 66(4):613-20. PubMed ID: 25975963
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antineutrophil Cytoplasmic Antibody-Associated Vasculitis in Korea: A Narrative Review.
    Choi CB; Park YB; Lee SW
    Yonsei Med J; 2019 Jan; 60(1):10-21. PubMed ID: 30554486
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevalence of Antineutrophil Cytoplasmic Antibody-Associated Vasculitis and Spatial Association With Quarries in a Region of Northeastern France: A Capture-Recapture and Geospatial Analysis.
    Giorgiutti S; Dieudonne Y; Hinschberger O; Nespola B; Campagne J; Rakotoarivelo HN; Hannedouche T; Moulin B; Blaison G; Weber JC; Dalmas MC; De Blay F; Lipsker D; Chantrel F; Gottenberg JE; Dimitrov Y; Imhoff O; Gavand PE; Andres E; Debry C; Hansmann Y; Klein A; Lohmann C; Mathiaux F; Guffroy A; Poindron V; Martin T; Korganow AS; Arnaud L
    Arthritis Rheumatol; 2021 Nov; 73(11):2078-2085. PubMed ID: 33881225
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neutrophilic Dermatoses in Antineutrophil Cytoplasmic Antibody-Associated Vasculitis: A French Multicenter Study of 17 Cases and Literature Review.
    de Boysson H; Martin Silva N; de Moreuil C; Néel A; de Menthon M; Meyer O; Launay D; Pagnoux C; Guillevin L; Puéchal X; Bienvenu B; Aouba A;
    Medicine (Baltimore); 2016 Mar; 95(11):e2957. PubMed ID: 26986103
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Revisiting the classification of clinical phenotypes of anti-neutrophil cytoplasmic antibody-associated vasculitis: a cluster analysis.
    Mahr A; Katsahian S; Varet H; Guillevin L; Hagen EC; Höglund P; Merkel PA; Pagnoux C; Rasmussen N; Westman K; Jayne DR;
    Ann Rheum Dis; 2013 Jun; 72(6):1003-10. PubMed ID: 22962314
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Echocardiographic features in patients with ANCA-associated vasculitis within 3 months before and after diagnosis.
    Ahn SS; Park ES; Jung SM; Song JJ; Park YB; Lee SW
    Clin Rheumatol; 2017 Dec; 36(12):2751-2759. PubMed ID: 28988280
    [TBL] [Abstract][Full Text] [Related]  

  • 18. ANCA-associated renal vasculitis is associated with rurality but not seasonality or deprivation in a complete national cohort study.
    Aiyegbusi O; Frleta-Gilchrist M; Traynor JP; Mackinnon B; Bell S; Hunter RW; Dhaun N; Kidder D; Stewart G; Joss N; Kelly M; Shah S; Dey V; Buck K; Stevens KI; Geddes CC; McQuarrie EP;
    RMD Open; 2021 Apr; 7(2):. PubMed ID: 33875562
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Risk of Cancers in Antineutrophil Cytoplasmic Antibody-Associated Vasculitis: Results from the Korea National Health Insurance Claims Database 2010-2018.
    Ahn SS; Han M; Yoo J; Jung SM; Song JJ; Park YB; Jung I; Lee SW
    J Clin Med; 2019 Nov; 8(11):. PubMed ID: 31694209
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cancer risks along the disease trajectory in antineutrophil cytoplasmic antibody associated vasculitis.
    Thet Z; Lam AK; Ranganathan D; Aung SY; Khoo TK
    Clin Rheumatol; 2020 Sep; 39(9):2501-2513. PubMed ID: 32219621
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.